American College Rhe …

American College Rheumatology Conference 2024. Washington convention center in washington, d.c. New phase 2b study results for zasocitinib, an investigational oral selective tyrosine kinase 2 (tyk2) inhibitor, will be presented at the american college of rheumatology (acr).

Acr convergence, the world’s premier rheumatology experience, is where thousands of rheumatologists and rheumatology professionals come together to network and get the latest. L09 • acr convergence 2024.